I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Glypican-1-targeted antibody–drug conjugate inhibits the gr..:
Uchida, Shun
;
Serada, Satoshi
;
Suzuki, Yuji
...
Neoplasia. 50 (2024) - p. 100982 , 2024
Link:
https://doi.org/10.1016/j.neo.2024.100982
RT Journal T1
Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.neo.2024.100982&Exemplar=1&LAN=DE A1 Uchida, Shun A1 Serada, Satoshi A1 Suzuki, Yuji A1 Funajima, Eiji A1 Kitakami, Kei A1 Dobashi, Kazumasa A1 Tamatani, Satomi A1 Sato, Yuichi A1 Beppu, Takaaki A1 Ogasawara, Kuniaki A1 Naka, Testuji PB Elsevier BV YR 2024 SN 1476-5586 JF Neoplasia VO 50 SP 100982 LK http://dx.doi.org/https://doi.org/10.1016/j.neo.2024.100982 DO https://doi.org/10.1016/j.neo.2024.100982 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)